Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-Hydroxytryptamine1A receptors and behavioral responses.

I Lucki1, S Wieland

  • 1Department of Psychiatry, University of Pennsylvania, Philadelphia 19104-4283.

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of Coherent ϕ(1020) Meson Photoproduction in Ultraperipheral PbPb Collisions at sqrt[s_{NN}]=5.36  TeV.

Physical review letters·2026
Same author

Search for New Physics in Jet Multiplicity Patterns of Multilepton Events at sqrt[s]=13  TeV.

Physical review letters·2025
Same author

Search for the Rare Decay D^{0}→μ^{+}μ^{-} in Proton-Proton Collisions at sqrt[s]=13.6  TeV.

Physical review letters·2025
Same author

Observation of Λ Hyperon Local Polarization in p-Pb Collisions at sqrt[s_{NN}]=8.16  TeV.

Physical review letters·2025
Same journal

CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

In memoriam: Jon Kar Zubieta, M.D., Ph.D.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Pharmacokinetics and concentration-behavioral effect relationships differ between brain subcompartments.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Auditory event-related potentials and psychosis dimensions.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Cultural humility in the teaching and practice of clinical care.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same journal

Kappa opioid receptors mediate aversion-and it matters.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
See all related articles

Behavioral studies reveal how 5-hydroxytryptamine1A (5-HT1A) agents like buspirone may work for anxiety and depression. Research on unconditioned, drug discrimination, and conditioned behaviors clarifies neuropharmacologic actions on 5-HT receptors.

Area of Science:

  • Neuroscience
  • Psychopharmacology
  • Behavioral Science

Background:

  • Understanding the mechanisms of psychotherapeutic drugs is crucial for treating anxiety and depression.
  • 5-hydroxytryptamine1A (5-HT1A)-selective agents, including buspirone and azapirones, are used clinically.
  • Behavioral studies offer insights into the neurobiological underpinnings of drug action.

Purpose of the Study:

  • To review the role of behavioral studies in elucidating the therapeutic actions of 5-HT1A-selective agents.
  • To discuss how different types of behavioral studies inform our understanding of buspirone and related drugs.
  • To highlight the connection between 5-HT receptor pharmacology and behavior.

Main Methods:

  • Review of existing literature on behavioral studies.

Related Experiment Videos

  • Analysis of unconditioned behaviors elicited by 5-HT agonists.
  • Examination of drug discrimination studies.
  • Evaluation of conditioned behaviors predicting clinical drug effects.

    • Main Results:

    • Behavioral studies have identified key neuropharmacologic actions of 5-HT1A agents.
    • These actions on 5-HT receptors are linked to potential therapeutic effects in anxiety and depression.
    • Different behavioral paradigms provide complementary information on drug mechanisms.

    Conclusions:

    • Behavioral research is essential for understanding the psychotherapeutic effects of 5-HT1A-selective drugs.
    • Further research is needed to address critical problems in linking 5-HT receptor subtypes to behavior.
    • This understanding can guide the development of more effective treatments for mood and anxiety disorders.